Magnesium levels in patients admitted to ICU and its impact on various outcomes.

K Satyanand; Ahirawadgi C Tukaram; Tiwari lavkush; Pakhetra Rajeev

Volume : VIII, Issue : VIII, August - 2018

Magnesium levels in patients admitted to ICU and its impact on various outcomes.

K Satyanand, Ahirawadgi C Tukaram, Tiwari Lavkush, Pakhetra Rajeev

Abstract :

Background: Role of magnesium therapy is very well known in torsades de pointes and preecllampsia. For other illnesses, the evidence is lacking .1There is a lack of consenensus as to the incidence of hypomagnesemia andhypermagnesimia, its association with mortality and morbidity. This study was undertaken with aview of addressing some of these issues. Methods – A total of 100 consecutive patients admitted in ICU of a tertiary care hospital from Jan 16 to Dec 16 were submitted for estimation of serum magnesium levels. Results– Sixtytwo (62%) were males and thirty two (38%) females. Mean age was 59.02 years(range 22–90). No patient was detected to have hypomagnesemia and 30 patients were detected to have hypermagnesemia. Mean Mg level of 2.337 mg/dl was found in the age group 22–53 years, 2.258 mg/ dl in age group 53–72 yrs and 2.329 mg/dl in the age roup of 72–90 yrs. Average duration of ICU stay ranged from 1 to 180 days with a mean of 6.025 with no correlation being found between duration of ventilatory support and magnesium levels (p=0.9363), Disease severity was assessed by APACHE II (range 0to 40), mean 20.21) and SOFA scores(range 0to 24, mean 7.42). No correlationwas found between APACHE II (p=0.6403) and SOFA (p=0.9497) score with magnesium levels. Fiftyseven 57% survived while 43patients (43%) died. Mean Magnesium level in survivors was 2.3 mg/dl. And in deceased was 2.2 mg/dl. No corelation was found between hospital stay, requirement of ventilatory support, disease severity and patient survival with magnesium levels.